Digital Biomanufacturing Market Size and Forecast to 2030

Digital biomanufacturing involves the digital technologies to improve the manufacturing process. It helps to enhanced the biological manufacturing by using computer aided design, verification and manufacture.

The global digital biomanufacturing market is estimated to be valued at US$ 17.92 billion in 2022 and is expected to exhibit a CAGR of 9.9% during the forecast period (2022-2030).

Figure 1. Global Digital Biomanufacturing Market, in Terms of Value (US$ Billion), By Region, 2022

DIGITAL BIOMANUFACTURING MARKET

To learn more about this report, request sample copy

Global Digital Biomanufacturing Market: Drivers

Emerging role of digital biomanufacturing is expected to drive the global market growth during the forecast period.

Digital biomanufacturing addresses unique aspects of biological activities and increase the data collection, monitoring, process control algorithms, automation, etc. Advances such as artificial intelligence (AI), automation, and robotics, are changing concepts of manufacturing in general from product development and factory operations to materials supply. Thus, emerging implementation of smart manufacturing in bio-based industries is likely boost the market growth in near future.

Digital Biomanufacturing Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 17.92 Bn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	9.9%	2030 Value Projection:	US$ 38.14 Bn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Type: Manufacturing Technologies, Analytical and Process Control Technologies, Others By Application: Bioprocess Optimization, Biomanufacturing Process Automation and Control, Others
Companies covered:	3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences
Growth Drivers:	Emerging role of digital biomanufacturing Expansion of digital biomanufacturing plants
Restraints & Challenges:	Lack of awareness regarding the technologically advanced services

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Figure 2. Global Digital Biomanufacturing Market Share (%), By Type, 2022

DIGITAL BIOMANUFACTURING MARKET

To learn more about this report, request sample copy

Expansion of digital biomanufacturing plants is expected to drive the global market growth over the forecast period

Key players are increasing their focus on expand the manufacturing process with innovative technologies to improve production process with research and development, paving the way for improved commercialization of important new medicines for patients . This in turn to drive the growth of market. For instance, in October 2019, Sanofi, a global biopharmaceutical company opened its first digitally enabled continuous manufacturing facility in Framingham, Massachusetts.

Global Digital Biomanufacturing Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sectors, which has been majorly impacted by the pandemic. Thus, surge in adoption of digital technologies in biopharma sector during the pandemic is leads to boosting the demand for digital bioprocessing and thereby drive the growth of market.

Global Digital Biomanufacturing Market: Restraints

Lack of awareness regarding the technologically advanced services in emerging countries are the factors that are likely to hamper the growth of market.

Key Players

Major players operating in the global digital biomanufacturing market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences

Missing comfort of reading report in your local language? Find your preferred language :

Transform your Strategy with Exclusive Trending Reports :

Home Healthcare Software Market

Medical Alert Systems Market

Mobile Health Apps And Solutions Market

Laboratory Information Systems Market

Pharmacy Benefit Management Market

U.S. Computer-Aided Detection (CAD) Mark...

Frequently Asked Questions

The global Digital Biomanufacturing Market size was valued at USD 17.92 billion in 2022 and is expected to reach USD 38.14 billion in 2030.

The global digital biomanufacturing market is estimated to be valued at US$ 17.92 billion in 2022 and is expected to exhibit a CAGR of 9.9% between 2022 and 2030.

Emerging role of digital biomanufacturing and expansion of digital biomanufacturing plants are the factors expected to drive the market growth over the forecast period.

Manufacturing technologies segment is holding a major market share in the market.

The major factor hampering growth of the market include lack of awareness regarding the technologically advanced services.

Major players operating in the market include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences